NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Vaccitech plc (NASDAQ: VACC)

 
VACC Technical Analysis
5
As on 9th Jun 2023 VACC STOCK Price closed @ 2.36 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.44 & Strong Sell for SHORT-TERM with Stoploss of 9.37 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VACCSTOCK Price

Open 2.50 Change Price %
High 2.50 1 Day -0.13 -5.22
Low 2.36 1 Week -0.08 -3.28
Close 2.36 1 Month 0.03 1.29
Volume 7900 1 Year -6.76 -74.12
52 Week High 11.75 | 52 Week Low 2.10
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
VACC
Daily Charts
VACC
Intraday Charts
Whats New @
Bazaartrend
VACC
Free Analysis
 
VACC Important Levels Intraday
RESISTANCE2.63
RESISTANCE2.54
RESISTANCE2.49
RESISTANCE2.44
SUPPORT2.28
SUPPORT2.23
SUPPORT2.18
SUPPORT2.09
 
VACC Forecast May 2024
4th UP Forecast8.49
3rd UP Forecast6.52
2nd UP Forecast5.31
1st UP Forecast4.09
1st DOWN Forecast0.63
2nd DOWN Forecast-0.59
3rd DOWN Forecast-1.8
4th DOWN Forecast-3.77
 
VACC Weekly Forecast
4th UP Forecast6.91
3rd UP Forecast5.45
2nd UP Forecast4.55
1st UP Forecast3.65
1st DOWN Forecast1.07
2nd DOWN Forecast0.17
3rd DOWN Forecast-0.73
4th DOWN Forecast-2.19
 
VACC Forecast2024
4th UP Forecast21.98
3rd UP Forecast15.69
2nd UP Forecast11.8
1st UP Forecast7.91
1st DOWN Forecast-3.19
2nd DOWN Forecast-7.08
3rd DOWN Forecast-10.97
4th DOWN Forecast-17.26
 
 
VACC Other Details
Segment EQ
Market Capital 473729152.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VACC Address
VACC
 
VACC Latest News
 
Your Comments and Response on Vaccitech plc
 
VACC Business Profile
Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. Its therapeutic programs include VTP-300 for the treatment of chronic hepatitis B infection; VTP-200 for the treatment of human papilloma virus infection; VTP-850 indicated for the treatment of prostate cancer; and VTP-600 for the treatment of non-small cell lung cancer. The company's prophylactic programs include VTP-400 for the prevention of herpes zoster or shingles; and VTP-500 for the prevention of Middle East respiratory syndrome. In addition, it is developing a COVID-19 vaccine with the University of Oxford, which is approved for use in various territories and licensed worldwide to AstraZeneca through Oxford University Innovation. The company was formerly known as Vaccitech Rx Limited and changed its name to Vaccitech plc in March 2021. Vaccitech plc was founded in 2016 and is headquartered in Oxford, the United Kingdom. Address: The Schrödinger Building, Oxford, United Kingdom, OX4 4GE
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service